Importance of luxury flow for critically ill patients receiving a left ventricular assist system

The presence of a significant organ dysfunction does not immediately exclude patients from consideration for treatment with a left ventricular assist system (LVAS). However, in treating morbid circulatory shock patients with multiple organ failure, it is important to know the preoperative and postoperative factor or factors related to the recovery of the damaged organ function. In this study, we retrospectively analyzed patients receiving a LVAS at our institution and tried to determine the important factors related to the survival of patients with multisystem failure. Twenty-seven patients who underwent LVAS placement at Saitama Medical School Hospital between 1993 and 2003 were included in this study. The preoperative risk factors analyzed were renal dysfunction, respiratory dysfunction, hepatic dysfunction, the existence of active infection, and the combination of all four factors. As a postoperative factor, the pump flow index (mean LVAS pump flow during the first 2 weeks after LVAS surgery divided by the body surface area) was analyzed. None of the analyzed preoperative factors could predict survival after LVAS surgery, but a pump flow index of less than 2.5 l/min/m² had a significant relationship with death after LVAS surgery. Further analysis revealed that all the patients with a pump flow index of 3.0 l/min/m² or more could overcome preoperative organ dysfunction. Congestive heart failure patients with multisystem failure need luxury pump flow for successful LVAS surgery; this factor could be especially important in device selection and postoperative management.     

Monitoring effects of α-human atrial natriuretic polypeptide (α-hANP) on left ventricular function in patients with essential hypertension with a cardiac probe

The effects of -hANP on left ventricular function were studied with a cardiac probe in ten patients with essential hypertension. Our data showed that intravenous administration of -hANP significantly elevated left ventricular function. At 5 min, the elevation of EF, RCO, ER, RSV, PFR were 13.23% (P<0.02), 12.7 (P<0.02), 0.618 (P<0.02), 0.133 (P<0.05), 0.283 (P<0.01), respectively. At 10 min, the increase of EF, ER, were 11.07% (P<0.02) and 0.233 (P<0.01), respectively. Atriopeptin significantly reduced systolic and diastolic blood pressure from 2 min to 20 min (P<0.001–0.05).Supported by IAEA Grant No. 4062/RI/RB     

Left ventricular function before and after kidney transplantation. A prospective study in patients with juvenile-onset diabetes mellitus

The aim of the present investigation was to discover whetherdisturbed left ventricular (LV) function limits renal replacementtherapy in patients with juvenile onset diabetes mellitus. Seventeenpatients given functioning kidney grafts were studied non-invasively(M-mode echocardiography, apexcardiography, phonocardiography)before renal transplant and an average of six, 13 and 44 monthsafter transplant. The main pretransplant findings were pronouncedLV hypertrophy with impaired diastolic LV function (prolongedrelaxation time + signs of decreased LV distensibility) anda hyperdynamic circulation. Most of these abnormalities were significantly less severe aftersuccessful kidney transplantation. LV mass decreased by 37%44 months after transplant (p<0.01) and LV diastolic andsystolic volumes decreased with a subsequent increase in ejectionfraction from 0.65 to 0.78 (p<0.01). The LV distensibilityand filling pattern improved significantly while the prolongedrelaxation time was unchanged. These findings imply that pretransplant disturbances in LV functionare related more to factors such as hypertension, volume overloadand uraemia than to diabetes per se because no pronounced improvementin the metabolic disorder resulting from diabetes can be expected,even after the most successful transplant. Disturbed LV functionshould not, therefore, exclude uraemic diabetics from renalreplacement.     

高血压及血糖水平对老年冠心病患者左室舒张功能的影响

目的：探讨年龄、高血压及血糖异常对老年冠心病（CHD）患者左室舒张功能的影响。方法：采用二次瓣彩色多普勒频谱测定中午CHD组24例、老年CHD组25例、合并症（CHD合并高血压、高血糖）组20例的左室舒张功能参数及空腹血糖值。结果：各组心脏指数和射血分数均正常。各线间血糖值相比（均为P＜0．05）。老年CHD组舒张早、晚期血清峰值比（E／A）下降（P＜0．01）,舒张早期血流加速度（AC）减低（P＜0．01）,以合并症组尤为明显（P＜0．001）。结论：随年龄增长,高血压及血糖异常可明显加重老年CHD患者左室舒张功能障碍。     

倍他乐克逆转高血压左室肥厚的临床观察

目的　比较 2药对高血压左室肥厚患者的疗效及运动后对心率、血压的影响。方法　采用随机分组法将 80例高血压左室肥厚的病人分成两组 ,倍他乐克组和硝苯地平组 ,治疗前后查超声心动图 ,测定IVST、PWT及LVMI ,心率及血压。结果　① 2药降压效果无明显差异。② 2组患者IVST、PWT、LVMI的下降幅度相同。③中度体力活动后 ,倍他乐克组心率增快 9± 2次 ,收缩压、舒张压上升均小于 3kPa(7 5mmHg) ,硝苯地平组心率增快 2 0± 4次 ,2组相比P <0 0 1,具有显著意义 ;收缩压、舒张压上升幅度均为 3 4± 1 2kPa(2 6±9mmHg) ,明显大于倍他乐克组。④结论　 2药对高血压患者的左心室肥厚有相似的逆转作用 ,但倍他乐克可减少体力活动时血压及心率的上升 ,对心脏更具有保护作用。     

保留左结肠动脉的腹腔镜直肠癌D3根治术对中晚期直肠癌患者的临床效果分析

目的探讨保留左结肠动脉的腹腔镜直肠癌D3根治术(Dixon)对中晚期直肠癌患者的临床效果分析。方法选取2015年12月至2018年1月60例中晚期直肠癌患者资料,根据术式不同分为保留组和未保留组,其中保留组(n=32)采用保留左结肠动脉的Dixon术,未保留组(n=28)采用高位结扎的Dixon术。采用SPSS 22.00软件对数据资料进行处理,围术期各项指标用(x±s)表示,采用独立t检验;术后并发症发生率、淋巴结清扫情况采用χ^2或Fisher检验,P<0.05表示差异有统计学意义。结果保留组肛门排气时间、边缘动脉弓压力显著少于未保留组(P<0.05),其余围术期指标比较均无统计学意义(P>0.05);两组清扫淋巴总数、转移淋巴结数及阳性淋巴结总数差异均无统计学意义(P>0.05),但保留组清扫第253组淋巴结数目显著大于未保留组(P<0.05);保留组吻合口漏发生率3.1%(1/32)显著少于未保留组10.7%(3/28),(P<0.05);两组患者术后1年肿瘤复发、转移发生率差异无统计学意义(P<0.05)。结论相比于高位结扎的Dixon术,保留左结肠动脉不增加术后肿瘤复发转移概率,并且可有效降低吻合口漏的发生率,具有良好的应用前景。     

The echocardiographic assessment of left ventricular performance during sevoflurane and halothane anesthesia

The cardiovascular effects of sevoflurane were studied and compared with those of halothane in 30 healthy patients. The patients were assigned to receive 1MAC sevoflurane (n = 10), 2MAC sevoflurane (n = 10) or 1MAC halothane (n = 10) in N₂O 2l·min^–1 and O₂ 4l·min^–1. The changes in left ventricular diastolic and systolic dimension (Dd and Ds), fractional shortening (FS), mean velocity of circumferential fiber shortening (mVcf), left ventricular diastolic and systolic volume (Vd and Vs), stroke volume (SV), ejection fraction (EF) and cardiac index (CI) were evaluated by echocardiography. Sevoflurane produced significant dose-dependent decreases in FS, mVcf, EF and SV, but no significant changes in Dd and Vd. Therefore, the decrease in SV was due mainly to the increase in left ventricular residual volume (Vs). One MAC halothane produced a more significant decrease in FS, mVcf, EF and SV, when compared to values obtained at 1MAC sevoflourane (P 0.01). CI was more significantly decreased with 1MAC halothane than with 1MAC and 2MAC sevoflurane (P 0.01). This was brought about by a slight decrease in HR with halothane and a slight increase in HR with sevoflurane, in addition to a smaller decrease in SV with sevoflurane than with halothane. This study suggests that sevoflurane may better preserve cardiac function as a pump in healthy patients, when compared to halothane.(Kasuda H, Akazawa S, Shimizu R.: The echocardiographic assessment of left ventricular performance during sevoflurane and halothane anesthesia. J Anesth 4: 295–302, 1990)     

依那普利治疗高血压左室肥厚和左室舒张功能

目的：探讨依即普利对高血压左室肥厚与左室舒张功能的治疗作用。方法：对符合ＷＨＯ诊断标准的原发性高血压左室肥厚,服用依那普 治疗,用彩色普勒超声心电图测定治疗前后左室肥厚、左室收缩及舒张功能指标。结果：治疗后室间隔厚度、左室后壁厚度、左室心肌重量均明显减少,舒张早期流速峰值明显增大,房缩期最大流速下降,两比值下降,左室射血分数无变化。结论：依那普利可有效地抑制并逆转左室肥厚,改善左室舒张功能。     

高血压病患者血清PCⅢ、LN、HA的变化--苯那普利干预实验

目的 通过观察高血压病患者血清Ⅲ型前胶原（ＰＣⅢ）、层粘连蛋白（ＬＮ）、透明质酸 （ＨＡ）含量的变化,以及苯那普利对其影响;探讨上述参数作为心肌肥厚指标的临床价值。评价苯那普利对高血压性心肌纤维化的影响。方法 测定６４例高血压病患者在用苯那普利前后血清中ＰＣ蝮、ＬＮ、ＨＡ水平的变化,并将左室心肌重指数（ＬＶＭＩ）与上述各参数作相关分析。结果 高血压伴左室肥厚组较高血压不伴左室肥厚组及正常对照组的血清